Editing Jeff Bezos (section)

=== Altos Labs ===
{{Main|Altos Labs}}
In September 2021, Bezos co-founded Altos Labs with [[Mail.ru]] founder [[Yuri Milner]]. Altos Labs is a well-funded biotechnology company dedicated to harnessing [[Induced pluripotent stem cells|cellular reprogramming]] to develop [[Life extension|longevity therapeutics]].<ref name="Regalado2021">{{cite news |last1=Regalado |first1=Antonio |title=Meet Altos Labs, Silicon Valley's latest wild bet on living forever |url=https://www.technologyreview.com/2021/09/04/1034364/altos-labs-silicon-valleys-jeff-bezos-milner-bet-living-forever/ |date=September 4, 2021 |work=[[MIT Technology Review]] |access-date=September 18, 2021 |url-status=live |archive-url=https://archive.today/20210905014902/https://www.technologyreview.com/2021/09/04/1034364/altos-labs-silicon-valleys-jeff-bezos-milner-bet-living-forever/ |archive-date=September 5, 2021 }}</ref> The company has recruited prominent scientists such as [[Juan Carlos Izpisua Belmonte|Juan Carlos Izpisúa Belmonte]] (known for work on rejuvenation through reprogramming), [[Steve Horvath]] (known for work in [[epigenetic clock|epigenetic aging clocks]]), and [[Shinya Yamanaka]] (the [[Nobel Prize for Physiology or Medicine|Nobel Prize]]-winning inventor of cellular reprogramming in mammalian cells).<ref name="Regalado2021" /> The company left [[stealth mode]] and launched on January 19, 2022, with a start capital of $3 billion and an executive team led by [[Hal Barron]].<ref>{{Cite web|last=Philippidis|first=Alex|date=January 19, 2022|title=Altos Labs Launches with $3B and a Focus on Reversing Disease, Aging|url=https://www.genengnews.com/aging/altos-labs-launches-with-3b-and-a-focus-on-reversing-disease-aging/|access-date=January 23, 2022|website=Genetic Engineering and Biotechnology News|language=en-US|archive-date=January 23, 2022|archive-url=https://web.archive.org/web/20220123161608/https://www.genengnews.com/aging/altos-labs-launches-with-3b-and-a-focus-on-reversing-disease-aging/|url-status=live}}</ref>